Menopausal hormone therapy for the primary prevention of chronic conditions: systematic review to update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations.
Nelson HD, Walker M, Zakher B, Mitchell J
Record ID 32013000762
English
Authors' objectives:
To update evidence on the effectiveness of hormone therapy in reducing risks for chronic conditions, its adverse effects, and differences among population subgroups for the U.S. Preventive Services Task Force.
Authors' recommendations:
Both hormone therapy regimens decreased fractures but increased stroke, thromboembolic events, gall bladder disease, and urinary incontinence. Estrogen plus progestin increased breast cancer and probable dementia, while estrogen alone decreased breast cancer.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.ncbi.nlm.nih.gov/books/NBK97827/pdf/TOC.pdf
URL for additional information:
http://www.ncbi.nlm.nih.gov/books/NBK97827/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Menopause
- Chronic Disease
- Hormone Replacement Therapy
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.